EUCTR2008-003342-29-IT进行中（未招募）不适用
Second line therapy with low dose fotemustine in progressive malignant gliomas - fotgm
ISTITUTI FISIOTERAPICI OSPITALIERI0 个研究点开始时间: 2008年6月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Anaplastic gliomas
- •Measurable disease
- •Previous treatment including alkilating agent
- •Age > 18 years
- •Karnofsky PS >= 60
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Presence of cardiac disease
- •Previous radiotherapy within 60 days
- •Previous treatment with fotemustine or other nitrosurees
研究者
相似试验
进行中（未招募）
不适用
Phase II multicenter study with Fotemustine and Temozolomide modulation in patients with metastatic melanoma (MM) - Phase II multicenter study with Fotemustine and Temozolomide in MMPatients with metastatic melanoma non pre-treated for advanced diseaseMedDRA version: 12.1Level: LLTClassification code 10027481Term: Metastatic melanomaEUCTR2009-016487-36-ITGOIM GRUPPO ONCOLOGICO MERIDIONALE
进行中（未招募）
不适用
Phase II trial evaluating fotemustine (Muphoran) treatment in patients with refractory or relapsing multiple myeloma - NDMedDRA version: 9.1Level: LLTClassification code 10028228Term: Multiple myelomamultiple myelomaEUCTR2008-001175-29-ITOSPEDALE POLICLINICO S. MATTEO
进行中（未招募）
1 期
A randomized, Phase III study of Fotemustine versus the Combination of Fotemustine and Ipilimumab in Patients with Metastatic Melanoma with brain metastasisEUCTR2012-004301-27-ITFONDAZIONE NIBIT160
招募中
3 期
Efficacy of oral fosfomycin as a step down therapy after treatment for upper urinary tract infection caused by extended-spectrum b-lactamase-producing Escherichia colipper urinary tract infectionESBL-producing E. coliAcute pyelonephritisOral fosfomycinStep down therapySwitching therapyUpper urinary tract infectionTCTR20171021001Research department, Faculty of Medicine Siriraj Hospital, Mahidol University140
已完成
不适用
Phase II study of first-line treatment by FOLFOXIRI+bevacizumab in patients with RAS mutant-type metastatic colorectal cancerColorectal CancerJPRN-UMIN000015152onprofit Organization Japan Clinical Cancer Research Organization60